Apexium Financial’s Morgan Stanley MS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$386K Sell
2,427
-78
-3% -$11.5K 0.02% 219
2025
Q2
$353K Buy
2,505
+15
+0.6% +$1.84K 0.02% 215
2025
Q1
$291K Sell
2,490
-71
-3% -$9.15K 0.02% 225
2024
Q4
$322K Sell
2,561
-636
-20% -$78.3K 0.02% 202
2024
Q3
$333K Hold
3,197
0.02% 178
2024
Q2
$311K Sell
3,197
-53
-2% -$5.04K 0.02% 176
2024
Q1
$306K Sell
3,250
-832
-20% -$73.3K 0.02% 176
2023
Q4
$381K Buy
4,082
+1,246
+44% +$99.7K 0.03% 195
2023
Q3
$232K Sell
2,836
-68
-2% -$5.9K 0.02% 191
2023
Q2
$248K Buy
+2,904
New +$248K 0.02% 193

Other funds holding MS

Apexium Financial's MS Position: Q3 2025 in Review

Apexium Financial reduced its Morgan Stanley (MS) stake by 3.1% in Q3 2025, selling an estimated $11.5K and leaving 2,427 shares worth $386K. The position accounts for 0.02% of the portfolio, ranked #219.

Apexium Financial first reported a position in MS in Q2 2023 and has held it in 10 quarters since. 2,258 funds tracked by Wall St. Rank hold MS as of Q3 2025.

  • Apexium Financial held 2,427 shares of Morgan Stanley worth $386K as of Q3 2025.
  • Apexium Financial sold 78 Morgan Stanley shares in Q3 2025, an estimated $11.5K.
  • Morgan Stanley made up 0.02% of Apexium Financial's portfolio in Q3 2025, its #219 holding.
  • Apexium Financial first reported a position in Morgan Stanley in Q2 2023 and has held it in 10 quarters since.
  • 2,258 funds tracked by Wall St. Rank held Morgan Stanley as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.